These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23740742)

  • 1. WhichCyp: prediction of cytochromes P450 inhibition.
    Rostkowski M; Spjuth O; Rydberg P
    Bioinformatics; 2013 Aug; 29(16):2051-2. PubMed ID: 23740742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
    Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
    J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SMARTCyp cytochrome P450 metabolism prediction server.
    Rydberg P; Gloriam DE; Olsen L
    Bioinformatics; 2010 Dec; 26(23):2988-9. PubMed ID: 20947523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties.
    Zahid H; Tayara H; Chong KT
    Arch Toxicol; 2024 Aug; 98(8):2647-2658. PubMed ID: 38619593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
    Usmani KA; Karoly ED; Hodgson E; Rose RL
    Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.
    Mishra NK; Agarwal S; Raghava GP
    BMC Pharmacol; 2010 Jul; 10():8. PubMed ID: 20637097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network.
    Li X; Xu Y; Lai L; Pei J
    Mol Pharm; 2018 Oct; 15(10):4336-4345. PubMed ID: 29775322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules.
    Zaretzki J; Bergeron C; Huang TW; Rydberg P; Swamidass SJ; Breneman CM
    Bioinformatics; 2013 Feb; 29(4):497-8. PubMed ID: 23242264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds.
    Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    Bioinformatics; 2015 Jun; 31(12):2046-8. PubMed ID: 25777527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors.
    Yap CW; Xue Y; Li ZR; Chen YZ
    Curr Top Med Chem; 2006; 6(15):1593-607. PubMed ID: 16918471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
    Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.
    Hickman D; Wang JP; Wang Y; Unadkat JD
    Drug Metab Dispos; 1998 Mar; 26(3):207-15. PubMed ID: 9492382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.
    Bojić M; Sedgeman CA; Nagy LD; Guengerich FP
    Eur J Pharm Sci; 2015 Jun; 73():49-56. PubMed ID: 25840124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.
    Krausz KW; Goldfarb I; Buters JT; Yang TJ; Gonzalez FJ; Gelboin HV
    Drug Metab Dispos; 2001 Nov; 29(11):1410-23. PubMed ID: 11602516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an in silico P450 profiler based on pharmacophore models.
    Schuster D; Laggner C; Steindl TM; Langer T
    Curr Drug Discov Technol; 2006 Mar; 3(1):1-48. PubMed ID: 16712462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server.
    Olsen L; Montefiori M; Tran KP; Jørgensen FS
    Bioinformatics; 2019 Sep; 35(17):3174-3175. PubMed ID: 30657882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
    Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
    Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.